Personalized Multi-peptide Vaccination in CLL Patients

Clinical trial NCT04688385 · COMPLETED

Trial details

NCT number: NCT04688385
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2020-12-23
Primary completion: 2024-10-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.